Epidemiology of rheumatic diseases

被引:231
|
作者
Sangha, O [1 ]
机构
[1] Univ Munich, Bavarian Publ Hlth Res Ctr, Fac Med, D-81549 Munich, Germany
关键词
osteoarthritis; rheumatoid arthritis; epidemiology; disease burden; health outcomes; NSAIDs;
D O I
10.1093/rheumatology/39.suppl_2.3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatic diseases are among the oldest diseases recognized. The classification of rheumatic diseases is sometimes difficult due to unknown aetiology and heterogeneity in their clinical presentation. Osteoarthritis (OA) and rheumatoid arthritis (RA) are the two most common rheumatic diseases, accounting for a large percentage of disability worldwide. The economic and social burden of these diseases is great. Their impact on both individuals and society results from a decreased quality of life, lost productivity and increased costs of health care. Without appropriate approaches to patient management and control of these diseases, this impact can be expected to increase as the population ages One of the challenges in studying OA and RA, and rheumatic diseases in general, is deriving epidemiological data that can be used to understand better the factors that contribute to the initiation and progression of these diseases. Only with such an understanding can significant progress be made in the diagnosis, treatment and management of patients.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 50 条
  • [31] Epidemiology of rheumatic diseases in indigenous populations in Latin-Americans
    Pelaez-Ballestas, Ingris
    Pons-Estel, Bernardo A.
    Burgos-Vargas, Ruben
    CLINICAL RHEUMATOLOGY, 2016, 35 : S1 - S3
  • [32] Epidemiology of rheumatic diseases in indigenous populations in Latin-Americans
    Ingris Peláez-Ballestas
    Bernardo A. Pons-Estel
    Rubén Burgos-Vargas
    Clinical Rheumatology, 2016, 35 : 1 - 3
  • [33] Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
    Prodromos I Sidiropoulos
    Stylianos A Karvounaris
    Dimitrios T Boumpas
    Arthritis Research & Therapy, 10
  • [34] Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases
    Kremers, HM
    Crowson, CS
    Gabriel, SE
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (04) : 819 - +
  • [35] Epidemiology and outcome of patients with rheumatic diseases in the intensive care unit
    Keysser, Gernot
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (10): : 925 - 931
  • [36] EPIDEMIOLOGY OF COCAINE AND HALLUCINOGEN USE DISORDER HOSPITALIZATIONS IN RHEUMATIC DISEASES
    Singh, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 488 - 488
  • [37] Electronic epidemiology and the risk of cardiovascular disease in inflammatory rheumatic diseases
    Ribeiro, Antonio Luiz P.
    Telles, Rosa Weiss
    HEART, 2016, 102 (05) : 337 - 338
  • [38] SELF-REPORTED RHEUMATIC DISEASES AND EARLY RETIREMENT IN PORTUGAL - RESULTS FROM THE PORTUGUESE EPIDEMIOLOGY STUDY ON RHEUMATIC DISEASES (EPIREUMAPT)
    Laires, P. A.
    Canhao, H.
    Gouveia, M.
    Rodrigues, A.
    Gouveia, N.
    Branco, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1289 - 1289
  • [39] Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients
    De Marco, Gabriele
    Cattaneo, Angelo
    Battafarano, Norma
    Lubrano, Ennio
    Carrera, Carlo G.
    Marchesoni, Antonio
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2012, 304 (09) : 719 - 726
  • [40] Epidemiology of rheumatic diseases in Iran from analysis of four COPCORD studies
    Davatchi, Fereydoun
    Sandoughi, Mahnaz
    Moghimi, Nasrin
    Jamshidi, Ahmad-Reza
    Banihashemi, Arash Tehrani
    Zakeri, Zahra
    Abdollahi, Bahar Sadeghi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (11) : 1056 - 1062